Episode Details
Back to Episodes
Discussing RA: Baricitinib dose reduction and switching to bDMARDs vs JAKis
Published 1 year, 3 months ago
Description
Join Professors Iain McInnes, Hans Bijlsma, and Peter Nash for the latest episode on The Immune-Mediated Inflammatory Disease Forum, where they discuss the latest updates in RA.
In this episode, they discuss two papers: baricitinib dose reduction in patients with RA achieving sustained disease control and switching to bDMARDs vs cycling among JAKis in patients with RA who are inadequate responders to JAKis.